about
Pretreatment with Resveratrol Prevents Neuronal Injury and Cognitive Deficits Induced by Perinatal Hypoxia-Ischemia in RatsBehavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia.Neuroprotection by the cannabinoid agonist WIN-55212 in an in vivo newborn rat model of acute severe asphyxia.Role of endocannabinoid system in mental diseases.Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer.Gene expression patterns in brain cortex of three different animal models of depression.Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex.Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment.Effects of 14-methoxymetopon, a potent opioid agonist, on the responses to the tail electric stimulation test and plus-maze activity in male rats: neuroendocrine correlates.Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats.Cerebrospinal fluid and plasma concentrations of nitric oxide metabolites are increased in dementia with Lewy bodies.Time course of opioid and cannabinoid gene transcription alterations induced by repeated administration with fluoxetine in the rat brain.Kappa- and delta-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice.Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors.Neurotransmitter amino acid in cerebrospinal fluid of patients with dementia with Lewy bodies.The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia.Docosahexaenoic Acid Reduces Cerebral Damage and Ameliorates Long-Term Cognitive Impairments Caused by Neonatal Hypoxia-Ischemia in Rats.Effect of subchronic corticosterone administration on α2-adrenoceptor functionality in rat brain: an in vivo and in vitro study.Prodynorphin gene deletion increased anxiety-like behaviours, impaired the anxiolytic effect of bromazepam and altered GABAA receptor subunits gene expression in the amygdala.Decreased GABAA and GABAB receptor functional activity in cannabinoid CB1 receptor knockout mice.Antidepressant-like properties of three new α2-adrenoceptor antagonists.Dynamics of expression and localization of the cannabinoid system in granulosa cells during oocyte nuclear maturation.Regulation of munc18-1 and syntaxin-1A interactive partners in schizophrenia prefrontal cortex: down-regulation of munc18-1a isoform and 75 kDa SNARE complex after antipsychotic treatment.Effect of chronic THC administration in the reproductive organs of male mice, spermatozoa and in vitro fertilizationThe endocannabinoid system in mental disorders: Evidence from human brain studiesChronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathwayChronic Effects of Cannabinoid Drugs on Monoaminergic Systems and the Role of Endocannabinoids and Cannabinoid Receptors in Human Brain DisordersCocaína y cerebroChronic fluoxetine reverses the effects of chronic corticosterone treatment on α2-adrenoceptors in the rat frontal cortex but not locus coeruleus
P50
Q27346253-AEC6A40D-444A-4606-B8DD-4DCE3348D26CQ30458391-BF519991-1582-44A5-BC6F-13E4D5309215Q30953929-A6A50769-49F1-4C4C-A1EF-B6EEFE42B66CQ35869726-D7F675B7-4DB4-4AAA-B5D8-2528235610F6Q37565204-5E347400-DDDD-4732-9F5E-D4CE3B337552Q38292402-CB331F80-0271-428C-9134-1DE0F72A18CBQ41668062-BE5D473B-21D4-4481-B311-83FA7D060C8EQ43299005-31C5ECB7-615E-4CB6-9667-9C27E1CB811AQ43943108-BCD8D04D-7732-4FE1-A263-D1BADE06A777Q44052454-1BC3221B-BF78-4CBE-AD4A-B4A7FC65F865Q44207328-57403719-12B2-4FD6-948B-FF996996087BQ44349238-8716683F-405F-43CE-B4F0-E8C562EFC9DFQ44350888-D68C580C-377E-4641-8AB1-85DDCE4692DDQ44842586-62F1A8A0-516D-463C-B841-4D2200E862D5Q45057807-C88DCA28-8B1C-4133-BC4A-E666077C46E3Q47850443-1A1B05A8-243B-4CD7-ADC5-0EF0B60050E8Q47894589-67134C74-143C-4595-AE4C-6CBC05C60223Q47946543-4377B2B2-6E45-4ABF-8BA5-16871E4A93D8Q48173710-D95A4EF8-270B-4B6F-BAD2-72A22486B71EQ48315314-1F2BF315-7860-4DE2-8724-E6E4CDFF63BCQ48375448-81DE9917-D291-4973-95C2-671B29328942Q48574708-09292858-4D75-4261-B232-EBC708B4B77EQ48852624-E556D5B4-1A0E-4E0D-9189-2246919613E8Q57647114-46424A95-9631-4751-98F3-12D67A2479A9Q57647117-69A02B46-8E6B-4F21-8196-0BD377867A7FQ57647123-FF79B61D-4D4F-4A92-8D37-99A3358F0BC6Q57647143-E4D19BDE-5120-4EE3-AB9A-743E8E792B53Q57647154-A3F9BB00-EC5C-4548-8378-2E69ACE0CF68Q92382157-6CDD8528-A308-42B9-AB1A-143E7CD71D87
P50
description
researcher ORCID id 0000-0002-1296-6895
@en
wetenschapper
@nl
name
Leyre Urigüen
@ast
Leyre Urigüen
@en
Leyre Urigüen
@es
Leyre Urigüen
@nl
type
label
Leyre Urigüen
@ast
Leyre Urigüen
@en
Leyre Urigüen
@es
Leyre Urigüen
@nl
prefLabel
Leyre Urigüen
@ast
Leyre Urigüen
@en
Leyre Urigüen
@es
Leyre Urigüen
@nl
P106
P1153
6507937833
P31
P496
0000-0002-1296-6895